Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity

Journal of the European Academy of Dermatology and Venereology : JEADV
Dagmar Wilsmann-TheisJ Wenzel

Abstract

Psoriasis is a chronic skin disease with deregulation of proteins in the immune system. These proteins include members of the heterogeneous S100 family, which have been discussed as potential biomarkers for disease severity. The aim of this study was to evaluate the impact of S100A7, S100A8, S100A9 and S100A12 as possible markers for disease activity in patients with psoriasis skin disease. S100A7, S100A8, S100A9 and S100A12 mRNA expression was determined in the skin of patients with psoriasis and controls (N = 341) by gene expression analyses. In addition, S100 serum levels were investigated by ELISA in an independent cohort of psoriasis patients (i) untreated, with different manifestations (skin/joints), (ii) under treatment (etanercept) and (iii) healthy controls, (N = 55). All S100-subtypes included are significantly upregulated in psoriasis skin lesions when compared with atopic dermatitis, lichen ruber and healthy donors. In untreated psoriasis patients, S100A12-serum levels showed the closest association with disease activity (PASI) (r = 0.542; P < 0.01). Serum levels decreased under treatment with etanercept (P < 0.05). Among the investigated S100-proteins, S100A12 showed the closest association with disease activity an...Continue Reading

References

Apr 22, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Ann-Marie BroomeRichard L Eckert
May 20, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dirk FoellJohannes Roth
Jun 12, 2004·The Journal of Investigative Dermatology·Richard L EckertKathleen Lee
Nov 20, 2008·The British Journal of Dermatology·K S AndersonC Enerbäck
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Sep 7, 2012·The Journal of Allergy and Clinical Immunology·Julia K GittlerEmma Guttman-Yassky
Dec 20, 2014·The Journal of Investigative Dermatology·Angelo Massimiliano D'ErmeJoerg Wenzel

❮ Previous
Next ❯

Citations

Apr 12, 2016·Journal of Proteomics·J ReindlH Rhode
Jun 19, 2016·The British Journal of Dermatology·K Yamanaka, H Mizutani
Oct 21, 2016·The Journal of Pathology·Rafael Leite DantasViktor Wixler
Nov 20, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A R J V VossenE P Prens
May 8, 2020·Mediators of Inflammation·Pavel BorskyVit Rehacek
May 14, 2017·Experimental Dermatology·Katja BieberMichael Kasperkiewicz
Nov 3, 2020·PPAR Research·Vladimir SobolevOxana Svitich
Nov 30, 2020·BMC Musculoskeletal Disorders·Christian S ThudiumMorten A Karsdal
Mar 9, 2021·BioMed Research International·Xiaoting Gong, Wei Wang
Jun 16, 2021·Allergology International : Official Journal of the Japanese Society of Allergology·Kiyofumi Yamanishi, Yasutomo Imai
Sep 10, 2021·The British Journal of Dermatology·Y YaoH C Ring

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

The Journal of Investigative Dermatology
Angelo Massimiliano D'ErmeJoerg Wenzel
Vestnik dermatologii i venerologii
L M Gol'dshteĭnP O Lasiĭchuk
Medizinische Klinik
G Ehlers, H J Rakoski
Ugeskrift for laeger
G RENSTRUP, J J PINDBORG
© 2021 Meta ULC. All rights reserved